ROCKVILLE, Md., Sept. 12 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA - News), a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced that Wayne T. Hockmeyer, Ph.D. has resigned from the Vanda Board of Directors effective September 7, 2006. Dr. Hockmeyer served as a member of the Board from 2004. He was also a member of the Board’s Compensation Committee and Nominating/Governance Committee.
